Aristippos Gennadios, President Softgel & Oral Technology at Catalent, Inc. (CTLT), sold 123,871 shares at $52.55 ($6.5M) on 2019-11-25, disclosed to the SEC on 2019-11-27.
Open-market sale of $6.5M CTLT by President Softgel & Oral Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.55 | 708 | $37K | 0.6% |
| 2 | $52.55 | 2,106 | $111K | 1.7% |
| 3 | $52.55 | 3,324 | $175K | 2.7% |
| 4 | $52.55 | 4,022 | $211K | 3.2% |
| 5 | $52.55 | 10,858 | $571K | 8.8% |
| 6 | $52.55 | 45,256 |
| $2.4M |
| 36.5% |
| 7 | $52.55 | 57,597 | $3.0M | 46.5% |
| Total | $52.55 avg | 123,871 | $6.5M | 100% |
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |